Takeda Pharmaceutical (TAK) Times Interest Earned (2017 - 2026)
Takeda Pharmaceutical's (TAK) quarterly Times Interest Earned came in at -$2.81 in Q1 2026, down 63.16% year-on-year from -$7.63 in Q1 2025, and down 136.66% quarter-over-quarter from $7.66 in Q4 2025.
Takeda Pharmaceutical (TAK) Times Interest Earned (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Times Interest Earned history runs 10 years deep, the most recent figure standing at -$2.81 for Q1 2026.
- On a quarterly basis, Times Interest Earned fell 63.16% year-over-year to -$2.81 in Q1 2026; TTM through Mar 2026 was -$1.29, a 27.56% increase from a year earlier, with the FY2026 full-year figure at $0.04, down 97.43% from the prior year.
- Times Interest Earned slipped to -$2.81 in Q1 2026 per TAK's latest filing, from $7.66 in the prior quarter.
- Across five years, Times Interest Earned topped out at $7.66 in Q4 2025 and bottomed at -$2.83 in Q2 2023.
- The 5-year median for Times Interest Earned is -$2.22 (2025), against an average of -$1.32.
- Across the five-year window, Times Interest Earned plunged 452.92% in 2023 and surged 414.74% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$1.84 in 2022, then grew by 2.3% to -$1.8 in 2023, then surged by 182.69% to $1.49 in 2024, then jumped by 414.74% to $7.66 in 2025, then plunged by 136.66% to -$2.81 in 2026.
- Per Business Quant, the three latest TAK Times Interest Earned figures stand at -$2.81 (Q1 2026), $7.66 (Q4 2025), and -$1.35 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.81 |
| Dec 31, 2025 | 7.66 |
| Sep 30, 2025 | -1.35 |
| Jun 30, 2025 | -2.22 |
| Mar 31, 2025 | -1.72 |
| Dec 31, 2024 | 1.49 |
| Sep 30, 2024 | -2.42 |
| Jun 30, 2024 | -2.79 |
| Mar 31, 2024 | -2.82 |
| Dec 31, 2023 | -1.80 |
| Sep 30, 2023 | -2.33 |
| Jun 30, 2023 | -2.83 |
| Mar 31, 2023 | -2.83 |
| Dec 31, 2022 | -1.84 |
| Sep 30, 2022 | -1.94 |
| Jun 30, 2022 | -2.71 |
| Mar 31, 2022 | 0.80 |
| Dec 31, 2021 | -2.49 |
| Sep 30, 2021 | -2.46 |
| Jun 30, 2021 | -3.50 |